Literature DB >> 10027310

Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas.

O K Yagi1, Y Akiyama, Y Yuasa.   

Abstract

Expression of CDX2, a caudal-related homeobox gene, was found to be decreased in colorectal carcinomas. Heterozygous null mutant mice as to Cdx2 develop multiple intestinal adenomatous polyps. To clarify the role of CDX2 in colorectal carcinogenesis, we determined its genomic structure, and searched for mutations of CDX2 in 49 sporadic colorectal carcinomas and ten hereditary non-polyposis colorectal cancers (HNPCC) without microsatellite instability. None of them exhibited a mutation. We further examined 19 HNPCC carcinomas with microsatellite instability for mutations in a (G)7 repeat site within CDX2. One of them (5.3%) exhibited one G insertion. Loss of heterozygosity was observed in 2 of the 20 (10%) informative sporadic carcinomas, and in one of the three (33.3%) informative HNPCC cancers. These data indicate that CDX2 may play only a minor role in colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027310      PMCID: PMC2362430          DOI: 10.1038/sj.bjc.6690068

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

Review 1.  Homeobox genes and axial patterning.

Authors:  W McGinnis; R Krumlauf
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

2.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

3.  Localization of the genes encoding two transcription factors, LMX1 and CDX3, regulating insulin gene expression to human chromosomes 1 and 13.

Authors:  M S German; J Wang; A A Fernald; R Espinosa; M M Le Beau; G I Bell
Journal:  Genomics       Date:  1994-11-15       Impact factor: 5.736

4.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

5.  Hox11 controls the genesis of the spleen.

Authors:  C W Roberts; J R Shutter; S J Korsmeyer
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

6.  A homeodomain protein related to caudal regulates intestine-specific gene transcription.

Authors:  E Suh; L Chen; J Taylor; P G Traber
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

7.  Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas.

Authors:  O K Yagi; Y Akiyama; T Nomizu; T Iwama; M Endo; Y Yuasa
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

8.  Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

Authors:  A Hemminki; P Peltomäki; J P Mecklin; H Järvinen; R Salovaara; M Nyström-Lahti; A de la Chapelle; L A Aaltonen
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

9.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

Authors:  S Markowitz; J Wang; L Myeroff; R Parsons; L Sun; J Lutterbaugh; R S Fan; E Zborowska; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

10.  Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1.

Authors:  S Li; E B Crenshaw; E J Rawson; D M Simmons; L W Swanson; M G Rosenfeld
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

View more
  10 in total

1.  Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Authors:  Jeong Mo Bae; Tae Hun Lee; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells.

Authors:  Fairouz Benahmed; Isabelle Gross; Dominique Guenot; Frédéric Jehan; Elisabeth Martin; Claire Domon-Dell; Thomas Brabletz; Michèle Kedinger; Jean-Noël Freund; Isabelle Duluc
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon.

Authors:  T Hinoi; M Tani; P C Lucas; K Caca; R L Dunn; E Macri; M Loda; H D Appelman; K R Cho; E R Fearon
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development.

Authors:  C Bonhomme; I Duluc; E Martin; K Chawengsaksophak; M-P Chenard; M Kedinger; F Beck; J-N Freund; C Domon-Dell
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

5.  Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system.

Authors:  D Qualtrough; T Hinoi; E Fearon; C Paraskeva
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

6.  CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

Authors:  Keyan Salari; Mary E Spulak; Justin Cuff; Andrew D Forster; Craig P Giacomini; Stephanie Huang; Melissa E Ko; Albert Y Lin; Matt van de Rijn; Jonathan R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

7.  The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.

Authors:  S Sivagnanasundaram; I Islam; I Talbot; F Drummond; J R Walters; Y H Edwards
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

8.  Relationships between the expressions of CDX1 and CDX2 mRNA and clinicopathologic features in colorectal cancers.

Authors:  Gwang Ha Kim; Dong Hyun Lee; Hyung Wook Kim; Jong Yun Cheong; Soo Boon Seo; Jeong Heo; Dae Hwan Kang; Geun Am Song; Mong Cho; Ung Suk Yang; Do Youn Park; Mi Ae Yoo
Journal:  Korean J Intern Med       Date:  2005-12       Impact factor: 2.884

9.  MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer.

Authors:  Aya Nishiuchi; Shigeo Hisamori; Masazumi Sakaguchi; Keita Fukuyama; Nobuaki Hoshino; Yoshiro Itatani; Shusaku Honma; Hisatsugu Maekawa; Tatsuto Nishigori; Shigeru Tsunoda; Kazutaka Obama; Hiroyuki Miyoshi; Yohei Shimono; M Mark Taketo; Yoshiharu Sakai
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

10.  The role of CDX2 in renal tubular lesions during diabetic kidney disease.

Authors:  Huiming Liu; Rui Yan; Luqun Liang; Huifang Zhang; Jiayi Xiang; Lingling Liu; Xiaohuan Zhang; Yanwen Mao; Wei Peng; Ying Xiao; Fan Zhang; Yuxia Zhou; Mingjun Shi; Yuanyuan Wang; Bing Guo
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.